News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Citi: Fundamentals of CN Healthcare Continue to Improve; Top Picks WUXI APPTEC, WUXI BIO, ALI HEALTH
The past FY25/1Q26 results confirmed sequential improvement in the fundamentals of China's healthcare sector, propelled by innovative drugs and CDMOs, Citi said in a report. Do...
Reset
Send
The window will close in 5 seconds
<Research>Citi: Fundamentals of CN Healthcare Continue to Improve; Top Picks WUXI APPTEC, WUXI BIO, ALI HEALTH
Close
Recommend
56
Positive
70
Negative
47
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

The past FY25/1Q26 results confirmed sequential improvement in the fundamentals of China's healthcare sector, propelled by innovative drugs and CDMOs, Citi said in a report. Domestic medical technology, healthcare services and pharmacy segments have bottomed out. Innovation is beginning to generate returns. Sales of innovative drugs are accelerating, while CXO order volumes have notched a record high.

Citi updated its Hong Kong Buy list, which includes HENGRUI PHARMA (01276.HK)  -1.050 (-1.683%)    Short selling $39.38M; Ratio 19.628%   , CSPC PHARMA (01093.HK)  +0.350 (+4.768%)    Short selling $185.59M; Ratio 24.126%   , ASCLETIS-B (01672.HK)  +0.500 (+3.309%)    Short selling $1.35M; Ratio 5.112%   , INNOVENT BIO (01801.HK)  -1.600 (-1.938%)    Short selling $247.89M; Ratio 28.194%   , WUXI APPTEC (02359.HK)  -1.000 (-0.763%)    Short selling $91.84M; Ratio 23.617%   , WUXI BIO (02269.HK)  -0.120 (-0.365%)    Short selling $110.97M; Ratio 16.044%   , ALI HEALTH (00241.HK)  0.000 (0.000%)    Short selling $153.16M; Ratio 34.469%   , MEDBOT-B (02252.HK)  +1.020 (+3.881%)    Short selling $11.08M; Ratio 5.809%   , MINDRAY BIO-MEDICAL (300760.SZ)  -5.260 (-3.324%)   , AIER EYE (300015.SZ)  -0.180 (-1.923%)   and YIFENG PHARMACY (603939.SH)  -0.530 (-2.488%)   . Its Top Sells include CR MEDICAL (01515.HK)  -0.040 (-1.563%)    Short selling $1.75M; Ratio 10.160%   and BLOOMAGE BIOTECH (688363.SH)  -0.520 (-1.316%)   .
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.) (A Shares quote is delayed for at least 15 mins.)

Related NewsCLSA Cuts ALI HEALTH (00241.HK) TP to HKD4.7; Innovative Drugs Remain Strategic Growth Driver

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.